Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Amdocs (DOX) over the last 17 years, with Q4 2025 value amounting to $1.2 billion.

  • Amdocs' Change in Accured Expenses rose 239709.07% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 57691.43%. This contributed to the annual value of $1.2 billion for FY2025, which is 870.07% down from last year.
  • As of Q4 2025, Amdocs' Change in Accured Expenses stood at $1.2 billion, which was up 239709.07% from $8.5 million recorded in Q3 2025.
  • In the past 5 years, Amdocs' Change in Accured Expenses registered a high of $1.2 billion during Q2 2024, and its lowest value of -$50.8 million during Q4 2024.
  • Its 5-year average for Change in Accured Expenses is $665.1 million, with a median of $973.7 million in 2021.
  • The largest annual percentage gain for Amdocs' Change in Accured Expenses in the last 5 years was 279033.74% (2022), contrasted with its biggest fall of 27904.29% (2022).
  • Quarter analysis of 5 years shows Amdocs' Change in Accured Expenses stood at -$3.1 million in 2021, then surged by 2790.34% to $82.1 million in 2022, then soared by 1415.23% to $1.2 billion in 2023, then plummeted by 104.08% to -$50.8 million in 2024, then skyrocketed by 2397.09% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q4 2025, $8.5 million for Q3 2025, and $1.2 billion during Q2 2025.